Anticonvulsant and sodium channel blocking activity of higher doses of clenbuterol

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 363, Issue 2, 2001, Pages 182-192

  Fischer, W ^a   Kittner, H ^a   Regenthal, R ^a   Malinowska, B ^b   Schlicker, E ^c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Anticonvulsants; Clenbuterol; Rat cardiomyocytes; Seizure models; Sodium channel; Whole cell voltage clamp

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR; CARBAMAZEPINE; CLENBUTEROL; PENTETRAZOLE; PHENOBARBITAL; SODIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; COMPLEX PARTIAL SEIZURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; ELECTRIC SHOCK; HYPOTENSION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; RAT; SEIZURE THRESHOLD; TACHYCARDIA; TONIC CLONIC SEIZURE;

ADRENERGIC BETA-AGONISTS; ANIMALS; ANTICONVULSANTS; CLENBUTEROL; ELECTROSHOCK; FEMALE; HIPPOCAMPUS; MALE; MICE; PROPANOLAMINES; RATS; RATS, WISTAR; SEIZURES; SODIUM CHANNELS; STEREOISOMERISM;

EID: 0035089353     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000341     Document Type: Article

References (66)

1. 2-adrenoceptors determined under in vivo conditions in the rat
2. The detection of new synthetic drugs in athlete's urine samples
3. 2-selective adrenoceptor antagonist (ICI 118, 551)
4. Food poisoning following consumption of clenbuterol-treated veal in Italy
5. Anabolic effects of clenbuterol after long-term treatment and withdrawal in the rat
6. + channels: Local anesthetics, antiarrhythmics and anticonvulsants
7. Structure and function of voltage-gated ion channels
8. Health hazards due to clenbuterol residues in food
9. + selectivity
10. Acute poisoning with clenbuterol - A case report
11. Interaction of beta adrenergic agonists and antagonists with beta adrenergic receptors in vivo
12. Chemical models of epilepsy with some reference to their applicability in the development of anticonvulsants
13. A note on a simple apparatus for detecting neurological deficit in rats and mice
14. 2-Rezeptoren
15. Stereotaxic atlases for the cat, rabbit and rat
16. A comparison of the neurochemical and behavioral effects of clenbuterol and desipramine
17. Pharmacological modulation of central monoaminergic systems and influence on the anticonvulsant effectiveness of standard antiepileptics in maximal electroshock seizure
18. Anticonvulsant and sodium channel blocking effects of ralitoline in different screening models
19. Structure and function of voltage-dependent sodium channels: Comparison of brain II and cardiac isoforms
20. Chronic beta-adrenergic stimulation increases in mice the sensitivity to methysergide and the number of cerebral high affinity serotonin binding sites (5-HT-1)
21. Effect of repeated administration of clenbuterol on the regulation of β-adrenoceptors in the central nervous system of the rat
22. Seizure in a patient receiving terbutaline
23. Modulation of oxotremorine-induced tremor by central beta-adrenoceptors
24. Myocardial and other muscle cell cultures
25. Improved patch-clamp techniques for high-resolution current recording from cell and cell-free membrane patches
26. Selective localization of cardiac SCN5A sodium channels in lim-bic regions of rat brain
27. Characterization of the calcium channel state transitions induced by the enantiomers of the 1, 4-dihydropyridine Sandoz 202 791 in neonatal rat heart cells. A nonmodulated receptor model
28. Antiarrhythmic agents: The modulated receptor mechanism of action of sodium and calcium channel blocking drugs
29. Principles of drug action: Structure-activity relationships and mechanisms
30. Bronchodilating and cardiovascular effects of intraduodenally and orally administered clenbuterol in dogs
31. Antiepileptic drug development: II. Anticonvulsant drug screening
32. Effect of catecholaminergic drugs on quinolinate- and kynurenine-induced seizures in mice
33. A simplified method of evaluating dose-effect experiments
34. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations
35. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models
36. Modulation of rat cardiac sodium channel by the stimulatory G protein subunit
37. Antiepileptic drug actions
38. 1-receptor agonists in the pithed and in the anaesthetized rat
39. Comparison of clenbuterol enantiomers using four psychopharmacological tests sensitive to β-agonists
40. Kindling model of epilepsy
41. The role of glutamate in epilepsy and other CNS disorders
42. Illegal use of beta-adrenergic agonists in the United States
43. Anticonvulsant and proconvulsant actions of alpha- and beta-noradrenergic agonists on epileptiform activity in rat hippocampus in vitro
44. Chronic β-blockade increases skeletal muscle β-adrenergic-receptor density and enhances contractile force
45. Beta adrenergic receptors facilitate norepinephrine release from rat hypothalamic and hippocampal slices
46. Pharmacological characterization of the discriminative stimulus effects of clenbuterol in rats
47. Effects of clenbuterol on central beta-1 and beta-2 adrenergic receptors of the rat
48. 2-stimulant. II. Effects on the cardiovascular system and smooth muscle organs
49. Antiepileptic drug development program
50. Modification of seizure activity by electrical stimulation: II. Motor seizure
51. Interactions of pentamethyl-enetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptor-ionophore complex
52. The pharmacologic basis of antiepileptic drug action
53. Antagonism of reserpine-induced hypothermia in mice by someb-adrenoceptor agonists
54. Comparative studies on the anticonvulsant effectiveness of nootropic drugs in kindled rats
55. + currents by isoproterenol
56. Class I antiarrhythmic drugs: Structure and function at the cardiac sodium channel
57. 2+ current in smooth muscle from pregnant rat uterus
58. Modulation of epileptiform discharges in rat limbic system in vitro by noradrenergic agents
59. Comparative assays of antiepileptic drugs in mice and rats
60. A combined study of sodium current and T-type calcium current in isolated cardiac cells
61. Effects of chlordiazepoxide, chlorpromazine, diazepam, diphenylhydantoin, flunitrazepam and haloperidol on the voltage-dependent sodium current in isolated mammalian brain neurons
62. Differential α- and β-adrenergic responsiveness of beating rat heart myocytes after stationary and non-stationary cultivation
63. Pharmacology of diphenylhydantoin and carbamazepine action on voltage-sensitive sodium channels
64. Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells
65. Multiple actions of b-adrenergic agonists on skeletal muscle and adipose tissue